Vo Tuan M, Duong Kim A, Tran Ly T-H, Bui Thanh C
Department of Obstetrics and Gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
J Obstet Gynaecol Res. 2019 Oct;45(10):2055-2061. doi: 10.1111/jog.14072. Epub 2019 Jul 31.
This study aimed to determine the recurrence rate and related risk factors of borderline ovarian tumors (BOT).
We conducted a retrospective cohort study with 433 patients who were surgically treated for primary BOT at Tu Du Hospital from 11/2008 to 09/2015. We used the life table method to estimate the cumulative recurrence rate. We used the log-rank test and Cox proportional hazard model to determine recurrence-associated factors.
Median follow-up time was 43 months (range: 3-105 months). Eighteen patients developed recurrence. The cumulative BOT recurrence rates at year 1, 2, 3 and 4 were 1.2% (95% confidence interval [CI] = 0.5-2.8), 3.0% (95% CI = 1.7-5.2), 4.6% (95% CI = 2.9-7.4), and 5.1% (95% CI = 3.2-8.0), respectively. In the final multivariate model, a higher recurrence rate was significantly associated with primary tumor stages (stage I vs stages II and III, hazards ratio [HR] = 4.44, 95% CI = 1.60-12.38), pre-operative tumor's capsule rupture (HR = 4.14, 95% CI = 1.78-9.64), and cystectomy (HR = 5.33, 95% CI = 1.43-19.91).
The overall BOT recurrence rate in women in southern Vietnam was moderate. Primary tumor stage, capsule rupture, and cystectomy were main factors associated with BOT recurrence. Appropriate follow-up strategies for patients with high-risk factors are needed for early detection and management of recurrence.
本研究旨在确定卵巢交界性肿瘤(BOT)的复发率及相关危险因素。
我们进行了一项回顾性队列研究,纳入了2008年11月至2015年9月在图度医院接受原发性BOT手术治疗的433例患者。我们采用寿命表法估计累积复发率。我们使用对数秩检验和Cox比例风险模型来确定复发相关因素。
中位随访时间为43个月(范围:3 - 105个月)。18例患者出现复发。第1、2、3和4年的BOT累积复发率分别为1.2%(95%置信区间[CI]=0.5 - 2.8)、3.0%(95% CI = 1.7 - 5.2)、4.6%(95% CI = 2.9 - 7.4)和5.1%(95% CI = 3.2 - 8.0)。在最终的多变量模型中,较高的复发率与原发性肿瘤分期(I期与II期和III期相比,风险比[HR]=4.44,95% CI = 1.60 - 12.38)、术前肿瘤包膜破裂(HR = 4.14,95% CI = 1.78 - 9.64)以及囊肿切除术(HR = 5.33,95% CI = 1.43 - 19.91)显著相关。
越南南部女性BOT的总体复发率适中。原发性肿瘤分期、包膜破裂和囊肿切除术是与BOT复发相关的主要因素。需要对具有高危因素的患者采取适当的随访策略,以便早期发现和处理复发情况。